Professor Davis is a consultant physician and endocrinologist at Fremantle Hospital, and professor of medicine at The University of Western Australia. He was awarded the Lifetime Achievement Award by the Australian Diabetes Society in 2021 for more than 40 years of research in diabetes. He has sat on numerous federal and state government advisory committees, and had involvement with leading advocacy groups for diabetes care.Dr Ele Ferrannini – MD
Italy
Dr Ferrannini is a Professor of Medicine at the University of Pisa, an adjunct clinical professor of medicine at the University of Texas Health Science Center, and a senior research associate at the National Research Council’s Institute of Clinical Physiology.
He is the 2020 recipient of the American Diabetes Association’s Banting Medal for Scientific Achievement, in recognition of his significant, long-term contributions to the understanding, treatment and prevention of diabetes.
Dr Ferrannini is renowned for his contributions to insulin resistance and associated disorders, ß-cell function and dysfunction in vivo, the incretin effect, and the cardiovascular complications of diabetes. Dr Ferrannini has also done pioneering work in therapeutics, including DPP-4 and SGLT2 inhibition and bariatric surgery, receiving recognition on the Clarivate™ list of Highly Cited Researchers.
Ms Kruger has been a certified nurse practitioner in diabetes for more than 40 years at Henry Ford Health in Detroit, Michigan, USA. Her role includes both clinical practice and research. She is board certified by the American Nurses Association Credentialing Center in Primary Care and by the American Association of Diabetes Educators in Advanced Diabetes Management. Ms Kruger is the past Chair of the American Diabetes Association’s (ADA) Research Foundation and has served on the ADA’s Research Policy Committee. She is also a past President of Health Care and Education for the ADA. She served as editor of Diabetes Spectrum from 2005-2008 and as the Editor in Chief of Clinical Diabetes from 2011-2016.
Dr Shanik is managing partner at Endocrine Associates of Long Island, PC and a clinical associate professor at Stony Brook University Hospital, New York. Dr Shanik has been an invited speaker at regional, national, and international meetings. He serves as principal investigator for many studies in diabetes and metabolism. Research interests include diabetes, cardiovascular and renal outcomes, major cardiovascular events, and novel therapies for diabetes.
Professor Thomas is a nephrologist, scientist and program leader in the Department of Diabetes at Monash University. He is founder and chief scientific officer of RAGE Biotech Ltd, and a Fellow of the Australian Academy of Health Medical Science. He is a leader in his field, publishing Nature review articles on the pathophysiology and management of diabetic kidney disease.
Dr Turchin is the director of quality for the division of endocrinology at Brigham and Women’s Hospital and an associate professor of medicine at Harvard Medical School. His research focuses on the treatment of patients with chronic cardiometabolic conditions using advanced electronic medical record data analytics, including causal inference, artificial intelligence and predictive modelling.
Ms Warshaw is a registered dietitian (RD) and a certified diabetes care and education specialist (CDCES) with more than 40 years of expertise in diabetes care and education. She holds a board certification in advanced diabetes management (BC-ADM), and is a consultant to several diabetes and nutrition-focused corporations.